Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Boehringer Ingelheim
Chinese Patent Office
McKesson
Colorcon
Mallinckrodt
Deloitte
Accenture

Generated: May 28, 2018

DrugPatentWatch Database Preview

ANEXSIA 7.5/650 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Anexsia 7.5/650 patents expire, and when can generic versions of Anexsia 7.5/650 launch?

Anexsia 7.5/650 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in ANEXSIA 7.5/650 is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for ANEXSIA 7.5/650
Drug patent expirations by year for ANEXSIA 7.5/650

US Patents and Regulatory Information for ANEXSIA 7.5/650

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt ANEXSIA 7.5/650 acetaminophen; hydrocodone bitartrate TABLET;ORAL 089725-001 Sep 30, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
US Department of Justice
Covington
Federal Trade Commission
Chinese Patent Office
Cipla
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.